Campanero M R
Departamento de Biología del Cáncer, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain.
Clin Transl Oncol. 2008 May;10(5):250-5. doi: 10.1007/s12094-008-0193-x.
Burkitt's lymphoma is a rapidly fatal tumor if untreated, but it is curable with intensive polychemotherapy. Unfortunately, the toxicities reported for its treatment in adults are poorly tolerated. Novel therapies aimed at specific molecular targets might prove to be less toxic. A better knowledge of the mechanisms involved in the pathogenesis of Burkitt's lymphoma would facilitate the identification of such targets. This review explores the current knowledge on the alterations found in the three main Burkitt's lymphoma variants.
伯基特淋巴瘤若不治疗,是一种迅速致命的肿瘤,但通过强化多药化疗可治愈。不幸的是,成人治疗中报告的毒性耐受性较差。针对特定分子靶点的新型疗法可能毒性较小。更好地了解伯基特淋巴瘤发病机制所涉及的机制将有助于识别此类靶点。本综述探讨了目前对三种主要伯基特淋巴瘤变体中发现的改变的认识。